Radiofrequency Ablation (RFA)

Treatment for Uterine Fibroids

Effectiveness
80%
Safety Score
60%
Clinical Trials
15
Participants
5K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
60
DangerousModerateSafe
Treatment Details
Time to Effect
1-3 months
Treatment Duration
One-time procedure
Evidence Quality
MODERATE
Confidence Score
80%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$500
Side Effect Mgmt:$0
Total Annual:$500
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOOD
ICER
$120,000/QALY
QALYs Gained
0.7
Outcome-Based Costs
Cost per Responder
$15,000
Comparison vs Myomectomy
Cost Difference
$-3,000/year
Less expensive
QALY Difference
-0.10 QALYs
Worse outcomes
Dominance
No dominance
Radiofrequency Ablation (RFA) Outcomes

for Uterine Fibroids

Efficacy Outcomes
Overall Effectiveness
+80%
Response Rate
+80%
Common Side Effects
Post-procedure pain
+60%
Cramping
+40%
Vaginal discharge
+8%
Infection
+1%

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
1 active trial recruiting for Radiofrequency Ablation (RFA) in Uterine Fibroids

Uterine Leiomyoma Treatment With Radiofrequency Ablation (ULTRA) Registry

NCT02100904ACTIVE NOT RECRUITING
View Study
578 participants
OBSERVATIONAL
Irvine, United States +11 more
Started: May 1, 2014
Completed Clinical Trials
9 completed trials for Radiofrequency Ablation (RFA) in Uterine Fibroids

Laparoscopic Radiofrequency Ablation (RFA) of Symptomatic Uterine Fibroids

NCT00874029COMPLETEDNA
View Study
137 participants
INTERVENTIONAL
Phoenix, United States +10 more
Started: Mar 1, 2009

Uterine Leiomyoma Treatment With Radiofrequency Ablation

NCT01840124COMPLETEDNA
View Study
26 participants
INTERVENTIONAL
Davis, United States +4 more
Started: Jul 1, 2013

Post Market TRUST - U.S.A. Study

NCT02163525COMPLETEDNA
View Study
114 participants
INTERVENTIONAL
Santa Monica, United States +8 more
Started: Jun 12, 2014

Tailored Radiofrequency Ablation of Uterine Myomas

NCT04091529COMPLETEDNA
View Study
54 participants
INTERVENTIONAL
Genoa, Italy
Started: Mar 1, 2017

Evaluation of Uterine Patency Following Sonography-guided Transcervical Ablation of Fibroids

NCT02844920COMPLETED
View Study
37 participants
OBSERVATIONAL
Mannheim, Germany +5 more
Started: Jul 20, 2017

Laparoscopic Uterine Sparing Techniques Outcomes and Reinterventions

NCT01750008COMPLETEDNA
View Study
51 participants
INTERVENTIONAL
Tübingen, Germany
Started: Nov 1, 2012

Post Market TRUST Study

NCT01563783COMPLETEDNA
View Study
84 participants
INTERVENTIONAL
Saskatoon, Canada
Started: Dec 1, 2012

Patient Centered Results for Uterine Fibroids

NCT02260752COMPLETED
View Study
3.09K participants
OBSERVATIONAL
San Francisco, United States +8 more
Started: Nov 1, 2015

Sonography Guided Transcervical Ablation of Uterine Fibroids

NCT02228174COMPLETEDNA
View Study
147 participants
INTERVENTIONAL
Phoenix, United States +22 more
Started: Oct 1, 2014